Sorry for the inconvenience.
Search again what you are looking for
Discovers, develops, manufactures and markets animal health products worldwide. Headquartered in Canada, the company was formed in 1979 as Vetrepharm to develop vaccines and other pharmaceutical-based products for the preventative health management of animal diseases. It markets a broad portfolio of products for companion animals, horses and the livestock industry, particularly a vaccine for Escherichia coli that has gained marketing approval in Canada but is still under investigation in the U.S.
Bioniche Animal Health has manufacturing facilities in Canada, the U.S. and Australia, and marketing subsidiaries in most major markets. With a 100-acre research farm, in-house laboratories, and established relationships with many global universities active in veterinary research, the company's research and development pipeline includes exciting new technologies in the areas of oncology, immunology and reproduction. Vetoquinol is a global animal health company based in France and serves both the livestock (cattle and pigs) and pet (dogs and cats) markets. An independent pure player, it designs, develops and markets veterinary drugs and non-medicinal products in Europe, the Americas and the Asia Pacific region. Bioniche Animal Health has been aquired by Vetoquinol.
Search again what you are looking for